NCT06402578

Brief Summary

Investigation into the effects of a 12-week digital physical activity programme, with or without physical education support on blood glucose control in patients with T2DM using HbA1c testing.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 7, 2024

Completed
25 days until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

1.1 years

First QC Date

March 13, 2024

Last Update Submit

May 3, 2024

Conditions

Keywords

HbA1cCholesterolResting Heart Rate

Outcome Measures

Primary Outcomes (1)

  • HbA1c testing

    blood will be take pre and post trial.

    12 weeks

Secondary Outcomes (1)

  • Cholesterol ratio testing

    12 weeks

Study Arms (3)

Control Group,

NO INTERVENTION

Control Group, will be issued with a smartwatch that is paired with a freely accessible App called Alexia® to record their PA. They will be asked to carry on with their daily activity and to record when they do any of their own physical activities that they do themselves routinely on an everyday basis during the 12 week study. They will not receive a 12 week PA programme.

Intervention 1

EXPERIMENTAL

Intervention 1, will be provided with a 12 week PA programme and asked to record their PA while they follow the programme during the 12 week study.

Diagnostic Test: HbA1c testing

Intervention 2

EXPERIMENTAL

Intervention 2, will also be provided with the same 12 week PA program and asked to record their PA while they follow the programme during the 12 week study. The participants in this group will also get support from a physical activity professional (PAP) who will be monitoring their 12 week journey. The PAP will be prompting the participant with weekly information as to why they are doing these exercises as well as supporting the participants to continue their programme as soon as non-adherence to the exercise program becomes apparent during the 12 week study.

Diagnostic Test: HbA1c testing

Interventions

HbA1c testingDIAGNOSTIC_TEST

Bloods will be take pre and post 12 week intervention.

Intervention 1Intervention 2

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnosis of T2DM in the last 3 years.
  • Age 18+ years.
  • Uses the English language as a primary or secondary language with the ability to read and write.
  • Lives in the United Kingdom.
  • Has no medical reason preventing participation in regular physical activity.
  • Has a SMART phone with access to the internet.

You may not qualify if:

  • Physical inability to participate in 12 weeks of physical activity.
  • Cardiac or cardiovascular surgery in the past 6 months.
  • Musculoskeletal issues that could be aggravated whilst participating in regular physical activity.
  • Presently participating in a weight loss programme.
  • Unable to commit to the 12-week feasibility study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Margret University Edinburgh

Edinburgh, Musselburgh, EH21 6UU, United Kingdom

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Philip Calvert, MSc

    PhD student

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Philip Calvert, MSc

CONTACT

Derek Santos, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: At the point of consent the participants will be randomised to one of three allocated groups. Control group, Intervention 1 or Intervention 2.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 13, 2024

First Posted

May 7, 2024

Study Start

June 1, 2024

Primary Completion

July 1, 2025

Study Completion

September 1, 2025

Last Updated

May 7, 2024

Record last verified: 2024-05

Locations